• Explore /
  • Poster
  • / Improving outcomes with brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma.

Improving outcomes with brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma.

Abstract Poster

Authors

null

David J. Straus

Memorial Sloan Kettering Cancer Center, New York, NY

David J. Straus , Graham P. Collins , Jan Andrzej Walewski , Pier Luigi Zinzani , Andrew Grigg , Anna M. Sureda , Árpád Illés , Tae Min Kim , Sergiy Alekseev , Lena Specht , Valeria Buccheri , Anas Younes , Joseph M. Connors , Ashish Gautam , Indra Purevjal , Keenan Fenton , Gerald Engley , Andrea Gallamini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Hodgkin Lymphoma

Clinical Trial Registration Number

NCT01712490

Citation

J Clin Oncol 36, 2018 (suppl; abstr 7534)

DOI

10.1200/JCO.2018.36.15_suppl.7534

Abstract #

7534

Poster Bd #

171

Abstract Disclosures

Similar Posters

First Author: Howland E. Crosswell

First Author: Judah D. Friedman

First Author: Scott F. Huntington

First Author: Jane N. Winter